Greg Ciongoli, Angel Investor

Greg Ciongoli is the founder and managing partner of Adiumentum Capital Management, launched in 2024 to focus on healthcare and biotech investments. He also serves on the boards of Zymeworks Inc. and Atara Biotherapeutics, bringing nearly two decades of experience from his prior role as a partner at The Baupost Group. His career reflects a focus on healthcare innovation, capital management, and long-term value creation. From directing investment strategies at Baupost to advising biotech companies at the board level, Ciongoli has consistently worked at the intersection of finance and life sciences. As an angel investor, Greg has backed ventures in sports and media. His recent investment in The 33rd Team highlights his interest in companies building platforms that combine content, community, and data-driven insights in the sports industry.